EUVIMEDEUVIMED entdecken
Crossref

Protective Effects of Niclosamide Ethanolamine Against Testosterone-Induced Benign Prostatic Hyperplasia in Rats

Ali Hussein Jasim, Ahmed Rahmah Abu-Raghif, Zeena Ayad Hussein iD

Drug Research · 2025-07 · 75 (06) · 225-234

DOI: 10.1055/a-2576-4153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, online erschienen am 28.04.2025. Verfasst von Ali Hussein Jasim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Niclosamide, Testosterone Propionate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benign prostatic hyperplasia is a common urological condition in aging men. The anthelmintic agent niclosamide ethanolamide exhibits a wide range of pharmacological activities. This study aimed to evaluate the protective effect of niclosamide ethanolamide in testosterone propionate-induced benign prostatic hyperplasia in rats along with elucidating the probable mechanism of action by investigating the influence on PPAR-γ and Wnt/β-catenin. 40 male Wistar rats were divided randomly into 4 groups. The healthy (control) group, received daily oral and subcutaneous administration of the vehicle. The Induced (TP) group, received only a daily dose of testosterone propionate 3 mg/kg, SC for 28 days. The treated groups (TP+FIN) and (TP+NE), received a concomitant administration of a daily dose of testosterone propionate along with finasteride 5 mg/kg/day and niclosamide ethanolamide 50 mg/kg/day respectively through oral gavage. Animals were euthanized on day 30 of the experiment and prostate tissue samples were collected to evaluate prostate index, prostate hyperplastic markers by ELISA, and gene expression by RT-qPCR. Results revealed that niclosamide ethanolamide significantly reduced prostate index compared to the induced (TP) group (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaNiclosamideTestosterone PropionateAnimalsMaleRatsRats, WistarPPAR gammaFinasterideProstateTestosteroneWnt Signaling Pathwaybeta CateninDisease Models, Animal

Substanzen

NiclosamidePPAR gammaTestosterone PropionateFinasterideTestosteronebeta CateninPPAR gamma, rat

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.

ORCID-Profile: Zeena Ayad Hussein

Zitieren

APA

Jasim, A. H., Abu-Raghif, A. R., & Hussein, Z. A. (2025). Protective Effects of Niclosamide Ethanolamine Against Testosterone-Induced Benign Prostatic Hyperplasia in Rats. Drug Research, 75(06), 225-234. https://doi.org/10.1055/a-2576-4153

Vancouver

Jasim AH, Abu-Raghif AR, Hussein ZA. Protective Effects of Niclosamide Ethanolamine Against Testosterone-Induced Benign Prostatic Hyperplasia in Rats. Drug Research. 2025;75(06):225-234. doi:10.1055/a-2576-4153

BibTeX
@article{Jasim2025,
  author = {Jasim, Ali Hussein and Abu-Raghif, Ahmed Rahmah and Hussein, Zeena Ayad},
  title = {Protective Effects of Niclosamide Ethanolamine Against Testosterone-Induced Benign Prostatic Hyperplasia in Rats},
  journal = {Drug Research},
  year = {2025},
  volume = {75},
  number = {06},
  pages = {225--234},
  doi = {10.1055/a-2576-4153}
}
Kostenlos starten →